DANDRITE opens call for 1-2 new group leaders

The Danish node of the Nordic EMBL Partnership for Molecular Medicine, DANDRITE, seeks 1-2 new group leaders in molecular and translational neuroscience.

2021.11.14 | Gretchen Repasky

DANDRITE has opened an international call for applications for one to two new group leaders in neuroscience to establish an independent research program that can both exploit and complement the expertise and research programs of current groups.

Focus on mechanistic investigations and translational science

Applications are particularly encouraged from candidates with strong programs in mechanism-based investigations and translational perspectives. Research programs can, for example, investigate protein-protein interaction networks in cell biology underlying intra- or intercellular signaling and function in the normal and diseased brain and its cells using advanced tools of e.g., imaging, chemical biology, single cell technologies, genetics, proteomics and bioinformatics.

Group leaders are expected to introduce novel topics and tools, strengthen synergies of on-going DANDRITE research, and build a program at international level that can support also collaborations of interdisciplinary and translational neuroscience at NeuroCampus Aarhus and within Danish neuroscience.

Generous start-up package and strong local research infrastructure

Candidates are offered a competitive start package of EUR 1.6M for the first five years and further funding can be expected from national and international funding bodies including a strong presence of private foundations in Danish research. Specific support programs are available for collaborations with other neuroscience communities in Denmark and for capital investments on equipment.

As a group leader you will be offered state-of-the-art laboratory facilities embedded in existing research infrastructures for neuroscience at all levels ranging from structure and function of molecules to advanced imaging, electrophysiology and functional/behavioral studies in transgenic models including for example induced pluripotent stem cells, brain organoids, fruit fly, zebrafish, mouse, and rat. Research at Aarhus University is in close proximity to clinical research at the top-ranked Aarhus University Hospital, and biotech support facilities are available. There will be ample opportunities for training and experience with academic teaching, public outreach, and start-up/translation.

The group leader program follows the EMBL model with a 5-year appointment and the possibility for a 4-year extension for a total of 9 years depending on a review concluding in the fourth year. 

Application deadline is January 31, 2022.

Learn more and apply.